Late immunocorrection after frontal orbital trauma surgery that involved the use of biocomposite
DOI:
https://doi.org/10.31288/oftalmolzh202025659Keywords:
frontal orbital trauma, immunoglobulins, cytokines, growth factor, immune complexes, humoral autoimmune responses, SYNTEKIST biocompositeAbstract
Purpose: To correct immune system deficiencies in patients with a problematic recovery course after frontal orbital trauma surgery that involved the use of SYNTEKIST biocomposite.
Material and Methods: Twenty facial bone trauma (FBT) patients with complicated wound healing in the late postoperative period were examined. The control group involved 10 healthy individuals. Patients of the rehabilitation treatment group were administered Imupret®, the commercial herbal medicinal product and an immunocorrective and antiphlogistic agent, and Eebisol, an IFN-? inducer and repairing agent. Serum levels of immunoglobulin (Ig)M, IgE, interleukin (IL)-1?, IL-10, gamma interferon (IFN-?), and transforming growth factor (TGF)-1? were measured.
Results: Two groups of patients who underwent FBT surgery that involved the use of biocomposite were identified. The group with a problematic late postoperative course exhibited stimulation of pro- and anti-inflammatory cytokines and absence of changes in serum levels of immunoglobulins and circulating immune complexes compared to controls and the group with uneventful late postoperative course. In addition, the group with a problematic late postoperative course exhibited decreased serum levels of TGF-? and IFN-?, which may be considered as pathogenetically significant factors involved in regeneration processes. No humoral autoimmune response to connective tissue antigens was found.
Conclusion: Increased serum levels of pro- and anti-inflammatory interleukins and decreased serum levels of TGF-? and, especially, IFN-?, are observed in patients with problematic regeneration. No humoral autoimmune response to connective tissue antigens was found in either group of patients with FBT. Stress mechanisms might be involved in decreased immunity levels in these patients.
References
1.Gorbunov VI, Likhterman LV, Gannushkina IV. [Immunology of traumatic brain injury]. Ulianovsk:SVNTS; 1996. Russian.
2.Gubler ЕV. [Informatics in pathology, clinical medicine and pediatrics]. Leningrad:Meditsina; 1990. Russian.
3.Demianov AV, Kotov AIu, Simbirtsev AG. [Diagnostic value of studying cytokine levels in clinical practice]. Cytokines and inflammation. 2003;3:20-8. Russian.
4.Drannik GN. [Clinical immunology and allergology]. Kyiv:Polygraph plus; 2010. Russian.
5.Kishchuk VV, Bondarchuk OD. [Using Syntekist biocomposites to repair bone defects in ear, nose and throat organs]. Zhurnal vushnykh, nosovykh i gorlovykh khvorob. 2007;5c:43-4. Ukrainian.
6.Kishchuk VV, Bondarchuk OD, Dmytrenko IV, Lobko KA. [Changes in humoral systemic immunity as an objective criterion of the rehabilitation process in patients with frontal basilar trauma]. Zhurnal vushnykh, nosovykh i gorlovykh khvorob. 2018;5:45. Ukrainian.
7.Kovalchuk LV, Gankovskaya LV, Meshkova RY. [Clinical immunology and allergology with the basics of general immunology]. Moscow: GEOTAR-Media; 2011. Russian.
8.Lysianyi NI, Pedachenko EG, Kadzhaia NV. [Features of autoimmune responses developing in recurrent TBI]. Immunologiia ta allergologiia. 2006;3:53-6. Ukrainian.
9.Nasonov EL. [Methodological aspects of measurements of circulating immune complexes with the use of polyethylene glycol]. Terapevticheskii arkhive. 1987;4:38-45. Russian.
10.Iakovenko VD. [Experimental and clinical grounding of the allergic diagnosis of chronical tonsillitis]. [Abstract of Cand Sc (Med) Thesis]. Kyiv: Prof. Kolomiichenko Institute of Otolaryngology; 1985. Russian.
11.Kabat EA, Mayer MM. [Experimental immunochemistry]. Moscow:Mir; 1968. Russian.
12.Matricon J, Barnish N, Ardid D. [Immunopathogenesis of inflammatory bowel disease]. Med Sci (Paris). 2010 Apr;26(4):405-10. French. https://doi.org/10.1051/medsci/2010264405
13.Zhuang J, Shackford SR, Schmoker JD, Anderson ML. The association of leukocytes with secondary brain injury. J Trauma. 1993 Sep;35(3):415-22. https://doi.org/10.1097/00005373-199309000-00014
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 О. Д. Бондарчук, В. В. Кіщук, О. Ф. Мельников, М. Д. Тимченко, Н. Д. Дідик
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
